spacer
home > pmps > autumn 2018 > encounters in transportation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Encounters in Transportation

Supply chain logistics experts understand that the transportation of any type of goods comes with their own set of challenges. When cold chain logistics are taken into account, a new set of unique obstacles are introduced.

To start, the cold chain market is growing. According to Qy Research Groups’ Global Cold Chain Logistics Market Size, Status and Forecast 2022 report, the global cold chain market is expected to reach US $426.2 billion by 2022. Pharmaceutical Commerce reported that cold chain logistics spending is forecast to grow to more than US $16 billion by 2020. Data points back to the rising demand for pharmaceuticals as one of the main factors driving demand for the temperature-controlled supply chain. This demand also stems from an aging population, which, in turn, is starting to require more medication, which must stay at specified temperatures.

By 2050, 16% of the world’s population will be 65 or older. Baby Boomers started turning 65 in 2011, and the American Hospital Association projects that by 2030, more than 60% of this generation will be managing more than one chronic condition. Additionally, Milliman reports that increased life expectancies will trigger greater consumption patterns in the population for medical services and pharmaceuticals.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Angela Kerr is Vice President of product portfolio at SpotSee. In this role, Angela focusses on building the company’s existing business and developing the next generation of cloud-based products that help customers costeffectively track their products around the globe. She has a Bachelor of Science degree in electrical engineering from Texas Tech University, US.
spacer
Angela Kerr
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals initiates partnership with American Biotech Zhittya for Parkinson’s disease treatment

3P and Zhittya began their relationship at the beginning of 2019 with 3P being selected as the CDMO to transfer the process for scaling up and performing cGMP manufacturing for clinical studies. After successfully achieving transfer of the process, 3P anticipates manufacturing of the first cGMP batch by the second quarter of 2020.
More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement